People with type 2 diabetes have had to follow a complicated routine of lifestyle adjustments, oral medications, and injectable therapy for a long time. Many patients find the thought of getting injections every day or week. However, with the advent of Rybelsus, the first oral GLP-1 receptor agonist, diabetes controlling has made a huge leap …
Continue reading “From Injection to Tablet: Why Rybelsus Is a Game-Changer in Diabetes Care”